Quarterly report pursuant to Section 13 or 15(d)

Statements of Operations

v3.19.3
Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Statements of Operations        
Product revenue $ 0 $ 0 $ 0 $ 0
Cost of product revenue 0 0 0 0
Gross profit 0 0 0 0
Operating expenses:        
Research and development 250,773 326,733 804,741 743,495
General and administrative 471,272 911,763 1,520,325 2,597,174
Total operating expenses 722,045 1,238,496 2,325,066 3,340,669
Loss from continuing operations before interest (722,045) (1,238,496) (2,325,066) (3,340,669)
Interest (income) expense, net 2,763 112 3,072 (36,817)
Loss from continuing operations (724,808) (1,238,608) (2,328,138) (3,303,852)
Loss from discontinued operations (78,796) (1,011,315) (768,047) (2,724,679)
Loss on sale of discontinued operations (9,107) 0 (9,107) 0
Net loss $ (812,711) $ (2,249,923) $ (3,105,292) $ (6,028,531)
Loss from continuing operations per share - basic and fully diluted (in dollars per share) $ (0.49) $ (0.88) $ (1.60) $ (2.36)
Loss from discontinued operations per share - basic and fully diluted (in dollars per share) (0.06) (0.73) (0.53) (1.94)
Net loss per share - basic and fully diluted (in dollars per share) $ (0.55) $ (1.61) $ (2.13) $ (4.30)
Weighted average number of shares outstanding - basic and fully diluted (in dollars) 1,474,001 1,401,348 1,460,507 1,401,060